Ahmad, T., et al. (2023). Cannabis use and pulmonary complications: A review of respiratory effects. Chest.
Alves, V. L., et al. (2021). Cannabidiol exposure during pregnancy and effects on placental development. Frontiers in Pharmacology, 12, 694089.
Bahji, A., Stephenson, C., Tyo, R., Hawken, E. R., & Seitz, D. P. (2020). Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: A systematic review and meta-analysis. JAMA Network Open, 3(4), e202370.
Brutlag, A., & Hommerding, H. (2018). Toxicology of marijuana in animals. Veterinary Clinics of North America: Small Animal Practice, 48(6), 1087–1102.
Carvalho, A. F., & Vieira-Coelho, M. A. (2022). Cannabis and psychosis: A critical review of evidence. Current Opinion in Psychiatry, 35(3), 201–207.
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2022). Clinical management of cannabis withdrawal. Addiction, 117(7), 2075–2095.
Cooper, Z. D., et al. (2023). Pulmonary effects of cannabis smoking: A review. Annals of the American Thoracic Society.
DeVuono, M. V., & Parker, L. A. (2020). Cannabinoid hyperemesis syndrome: A review of potential mechanisms. Cannabis and Cannabinoid Research, 5(2), 132–144.
Drummer, O. H., et al. (2019). Cannabis use and driving impairment: Toxicological considerations. Forensic Science International, 300, 111–119.
D’Souza, D. C., et al. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals. Neuropsychopharmacology, 29(8), 1558–1572.
D’Souza, D. C., et al. (2016). Cannabinoid receptor availability and cannabis withdrawal severity. Biological Psychiatry, 79(7), 558–567.
Goodwin, R. S., Darwin, W. D., Chiang, C. N., Shih, M., Li, S. H., & Huestis, M. A. (2008). Urinary elimination of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in cannabis users during continuously monitored abstinence. Journal of Analytical Toxicology, 32(8), 562–569.
Grewal, R. S., & George, T. P. (2017). Cannabis-induced psychosis: A review. Current Psychiatry Reports, 19(12), 97.
Hashibe, M., Straif, K., Tashkin, D. P., Morgenstern, H., Greenland, S., & Zhang, Z. F. (2006). Epidemiologic review of marijuana use and cancer risk. Alcohol, 35(3), 265–275.
Kerr, D. M., & Ye, Y. (2022). Toxicity of cannabinoids: Current understanding. Toxicology Reports, 9, 1334–1345.
Ksir, C., & Hart, C. L. (2016). Cannabis and psychosis: A critical overview. Current Psychiatry Reports, 18(2), 12.
Kulpa, J., Lefever, T. W., Trexler, K. R., Henderson, R. G., MacNair, L., Toth, M. L., Vanapalli, S. A., Rahman, M., Gupta, S., & Bonn-Miller, M. O. (2023). Toxicity of cannabigerol: Examination of long-term toxicity and lifespan in Caenorhabditis elegans and rats. Cannabis and Cannabinoid Research.
Oliveira, J. P., et al. (2022). Cannabis use and cardiovascular outcomes: A systematic review. Journal of the American Heart Association, 11(1), e024011.
Olsson, M. O., et al. (2023). Adverse effects in patients using medical cannabis: A registry-based study. Medical Cannabis and Cannabinoids.
Pacher, P., Steffens, S., & Haskó, G. (2017). Cardiovascular effects of cannabinoids. British Journal of Pharmacology, 174(11), 1514–1526.
Proal, A. C., Fleming, J., Galvez-Buccollini, J. A., & Delisi, L. E. (2014). A controlled family study of cannabis users with and without psychosis. Schizophrenia Research, 152(1), 283–288.
Rebuli, M. E., et al. (2023). E-cigarette or vaping-associated lung injury (EVALI): Clinical features and mechanisms. New England Journal of Medicine.
Reis, J. P., Auer, R., Bancks, M. P., et al. (2017). Association of marijuana use with cardiovascular outcomes. American Journal of Cardiology, 120(3), 354–359.
Sagar, K. A., Dahlgren, M. K., Racine, M. T., et al. (2020). Joint effects of cannabis use and clinical symptoms in medical cannabis patients. Cannabis and Cannabinoid Research, 5(3), 257–266.
Sulak, D. (2021). The safety profile of cannabinoids: Clinical considerations. Journal of Cannabis Research, 3, 27.
Swenson, E. R., et al. (2023). Effects of cannabidiol exposure on fetal and placental development. Toxicological Sciences.
Tashkin, D. P. (2002). Effects of marijuana smoking on the lung. Annals of the American Thoracic Society.
Tashkin, D. P., & Roth, M. D. (2019). Pulmonary effects of inhaled cannabis. Current Opinion in Pulmonary Medicine, 25(2), 153–161.
Thompson, G. R., et al. (1973). Toxicity and pharmacology of THC in animal models. Toxicology and Applied Pharmacology.
Vanin, A. A., et al. (2024). Cannabidiol effects on placental biology and fetal development. Frontiers in Pharmacology.
Walsh, Z., Gonzalez, R., Crosby, K., S. Thiessen, M., Carroll, C., & Bonn-Miller, M. O. (2017). Medical cannabis and mental health: A review of adverse effects. Current Addiction Reports, 4(3), 215–225.
Zaga, V., et al. (2021). Pulmonary complications associated with cannabis use. European Respiratory Review, 30(160), 200276.